Xenetic Biosciences, Inc.
XBIO
$3.02
-$0.12-3.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.05% | 13.30% | -2.94% | 5.63% | -1.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.05% | 13.30% | -2.94% | 5.63% | -1.57% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 19.05% | 13.30% | -2.94% | 5.63% | -1.57% |
| SG&A Expenses | -19.64% | -22.59% | -24.31% | -6.69% | -4.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.33% | -10.38% | -24.13% | -11.66% | -4.97% |
| Operating Income | 32.58% | 24.09% | 34.80% | 20.35% | 6.90% |
| Income Before Tax | 32.31% | 22.59% | 34.35% | 17.99% | 4.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 32.31% | 22.59% | 34.35% | 17.99% | 4.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 32.31% | 22.59% | 34.35% | 17.99% | 4.22% |
| EBIT | 32.58% | 24.09% | 34.80% | 20.35% | 6.90% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 36.62% | 22.68% | 34.51% | 18.38% | 4.98% |
| Normalized Basic EPS | 36.63% | 22.68% | 34.51% | 18.38% | 4.98% |
| EPS Diluted | 36.62% | 22.68% | 34.51% | 18.40% | 5.01% |
| Normalized Diluted EPS | 36.63% | 22.68% | 34.51% | 18.38% | 4.98% |
| Average Basic Shares Outstanding | 10.40% | 0.11% | 0.25% | 0.49% | 0.86% |
| Average Diluted Shares Outstanding | 10.40% | 0.11% | 0.25% | 0.49% | 0.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |